NDAOPHTHALMICSOLUTION/DROPS
Approved
Mar 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Visine L.R. is an ophthalmic decongestant containing oxymetazoline hydrochloride, a selective alpha-adrenergic agonist delivered as eye drops. It is indicated for temporary relief of redness of the eye due to minor irritation caused by allergens, chlorinated water, air pollution, or dust. The drug works by constricting blood vessels in the eye to reduce redness and restore white appearance within minutes.
LOE Approaching
Approaching loss of exclusivity after 35 years; team size likely optimized for defensive maintenance rather than growth investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Started Apr 2019
1,105 enrolled
Rosacea
Career Relevance
Working on Visine L.R. positions you in mature-market brand stewardship, requiring excellence in consumer engagement, retail partnership, and margin protection rather than market expansion. Career progression emphasizes operational efficiency, competitive pricing strategy, and preparation for generic competition—skills highly transferable to other OTC franchises and defensive portfolio management.
Brand Manager
Worked on VISINE L.R. at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.